REPLIGEN CORP (RGEN) Forecast, Price Target & Analyst Ratings

NASDAQ:RGEN • US7599161095

Current stock price

116.95 USD
-0.83 (-0.7%)
At close:
116.95 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for REPLIGEN CORP (RGEN).

Forecast Snapshot

Consensus Price Target

Price Target
$191.89
+ 64.08% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 27, 2026
Period
Q1 / 2026
EPS Estimate
$0.40
Revenue Estimate
196.12M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.43%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$191.89
Upside
+ 64.08%
From current price of $116.95 to mean target of $191.89, Based on 28 analyst forecasts
Low
$153.52
Median
$195.84
High
$231.00

Price Target Revisions

1 Month
0.19%
3 Months
-0.61%

Price Target Summary

28 Wall Street analysts provided a forecast for the next 12 months for RGEN. The average price target is 191.89 USD. This implies a price increase of 64.08% is expected in the next year compared to the current price of 116.95.
The average price target has been revised downward by 0.61% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RGEN Current Analyst RatingRGEN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

RGEN Historical Analyst RatingsRGEN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
81.43%
RGEN was analyzed by 28 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about RGEN.
In the previous month the buy percentage consensus was at a similar level.
RGEN was analyzed by 28 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-06Evercore ISI GroupMaintains Outperform -> Outperform
2026-03-23HC Wainwright & Co.Maintains Buy -> Buy
2026-02-25UBSMaintains Buy -> Buy
2026-02-25BarclaysMaintains Overweight -> Overweight
2026-02-25Wells FargoMaintains Overweight -> Overweight
2026-02-25Evercore ISI GroupMaintains Outperform -> Outperform
2026-01-16UBSMaintains Buy -> Buy
2025-12-15BarclaysMaintains Overweight -> Overweight
2025-12-15Wells FargoMaintains Overweight -> Overweight
2025-10-29BarclaysMaintains Overweight -> Overweight
2025-10-29Canaccord GenuityMaintains Hold -> Hold
2025-10-07Evercore ISI GroupMaintains Outperform -> Outperform
2025-10-02BarclaysMaintains Overweight -> Overweight
2025-10-01HSBCInitiate Buy
2025-09-22Evercore ISI GroupUpgrade In-Line -> Outperform
2025-09-12JefferiesMaintains Hold -> Hold
2025-09-03HC Wainwright & Co.Reiterate Buy -> Buy
2025-07-30RBC CapitalMaintains Outperform -> Outperform
2025-07-30Wells FargoMaintains Overweight -> Overweight
2025-07-08Evercore ISI GroupMaintains In-Line -> In-Line
2025-06-24BarclaysInitiate Overweight
2025-05-05HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-30RBC CapitalMaintains Outperform -> Outperform
2025-04-29JP MorganMaintains Overweight -> Overweight
2025-04-17Canaccord GenuityMaintains Hold -> Hold

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 27, 2026
Period
Q1 / 2026
EPS Estimate
$0.40
Revenue Estimate
196.12M
Revenue Q2Q
15.93%
EPS Q2Q
1.34%
Number of Analysts
21

Next Earnings Revisions

Revenue (1 Month)
0.19%
Revenue (3 Months)
0.49%
EPS (1 Month)
3.29%
EPS (3 Months)
-13.63%

Next Earnings Summary

RGEN is expected to report earnings on 4/27/2026. The consensus EPS estimate for the next earnings is 0.4 USD and the consensus revenue estimate is 196.12M USD.
The next earnings revenue estimate has been revised upward by 0.49% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RGEN revenue by date.RGEN revenue by date.
632.362M
-21.10%		634.439M
0.33%		738.256M
16.36%		843.84M
14.30%		966.37M
14.52%		1.114B
15.28%		1.306B
17.24%		1.541B
17.99%		1.914B
24.21%		2.382B
24.45%		2.943B
23.55%
EBITDA
YoY % growth
RGEN ebitda by date.RGEN ebitda by date.
147.988M
-40.09%		81.728M
-44.77%		138.047M
68.91%		170.18M
23.28%		212.6M
24.93%		268.23M
26.17%		358.26M
33.56%		453.35M
26.54%		592.93M
30.79%		580.33M
-2.13%		688.52M
18.64%
EBIT
YoY % growth
RGEN ebit by date.RGEN ebit by date.
79.903M
-59.23%		12.055M
-84.91%		59.302M
391.93%		118.73M
100.21%		162.13M
36.55%		206.75M
27.52%		326.66M
58.00%		421.77M
29.12%		543.35M
28.83%		626.18M
15.24%		781.22M
24.76%
Operating Margin
RGEN operating margin by date.RGEN operating margin by date.
12.64%1.90%8.03%14.07%16.78%18.56%25.01%27.37%28.39%26.29%26.55%
EPS
YoY % growth
RGEN eps by date.RGEN eps by date.
1.73
-47.26%		1.48
-14.45%		1.71
15.54%		1.99
16.45%		2.49
25.25%		3.17
27.15%		4.32
36.25%		5.44
26.02%		6.85
25.89%		6.68
-2.53%		8.05
20.46%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		0.40
1.34%		0.47
28.22%		0.53
15.07%		0.60
23.23%		0.54
36.32%		0.62
31.74%		0.67
26.13%		0.76
25.46%		0.72
33.29%		0.79
25.91%		0.85
27.03%		0.93
22.99%
Revenue
Q2Q % growth		196.12M
15.93%		207.55M
13.81%		213.75M
13.21%		226.42M
14.40%		223.48M
13.95%		238.96M
15.13%		246.24M
15.20%		259.16M
14.46%		251.59M
12.58%		264.5M
10.69%		276.64M
12.35%		290.09M
11.93%
EBITDA
Q2Q % growth		34.488M
26.54%		40.443M
-26.26%		44.787M
-40.77%		50.827M
-47.39%		45.768M
32.71%		52.469M
29.74%		56.196M
25.47%		62.934M
23.82%		52.418M
14.53%		59.925M
14.21%		65.321M
16.24%		75.235M
19.55%
EBIT
Q2Q % growth		21.983M
157.08%		27.385M
70.54%		31.241M
85.68%		37.496M
109.85%		32.411M
47.44%		39.398M
43.87%		43.008M
37.67%		50.241M
33.99%		42.146M
30.04%		49.664M
26.06%		55.355M
28.71%		65.392M
30.16%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RGEN Yearly Revenue VS EstimatesRGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B 2.5B
RGEN Yearly EPS VS EstimatesRGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.86%
EPS Next 5 Year
26.07%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
14.21%
Revenue Next 5 Year
15.56%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
41.89%
EBIT Next 5 Year
37.01%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

REPLIGEN CORP / RGEN Forecast FAQ

What do analysts expect the price target to be for REPLIGEN CORP (RGEN)?

28 analysts have analysed RGEN and the average price target is 191.89 USD. This implies a price increase of 64.08% is expected in the next year compared to the current price of 116.95.

What is the next earnings date for RGEN stock?

REPLIGEN CORP (RGEN) will report earnings on 2026-04-27, before the market open.

What are the consensus estimates for REPLIGEN CORP (RGEN) next earnings?

The consensus EPS estimate for the next earnings of REPLIGEN CORP (RGEN) is 0.4 USD and the consensus revenue estimate is 196.12M USD.

How many analysts cover REPLIGEN CORP (RGEN) stock?

The number of analysts covering REPLIGEN CORP (RGEN) is 28.